[Postinfarction cardiac remodeling--clinical consequences]
- PMID: 20043580
[Postinfarction cardiac remodeling--clinical consequences]
Abstract
Despite the considerable progress in the setting of invasive and pharmacological treatment still in about 20-30% patients with myocardial infarction in long-term observation an unfavourable post-infarction remodeling along with development of LV dilatation is to be seen. The heart forms the structural and functional unity, thus morphological changes due to cardiac post-infarction remodeling process are accompanied by systolic and diastolic myocardial dysfunction, which in consequence may lead to appearance of heart failure. In recent years our knowledge regarding causative factors of post-infarction cardiac remodeling has been remarkably widening and in the light of accumulating data indicating the possibility of LV remodeling regression, elaboration of the new specific-orientated methods of counteracting its uneventful consequenses is a matter of time.
Similar articles
-
Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.Circ Res. 2009 Mar 13;104(5):699-706. doi: 10.1161/CIRCRESAHA.108.189746. Epub 2009 Jan 24. Circ Res. 2009. PMID: 19168865
-
Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction.J Card Fail. 2002 Dec;8(6 Suppl):S465-71. doi: 10.1054/jcaf.2002.129289. J Card Fail. 2002. PMID: 12555159 Review.
-
Pathophysiology of heart failure following myocardial infarction.Heart. 2005 May;91 Suppl 2(Suppl 2):ii14-6; discussion ii31, ii43-8. doi: 10.1136/hrt.2005.062034. Heart. 2005. PMID: 15831601 Free PMC article. Review.
-
Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.Circulation. 2003 Oct 28;108(17):2134-40. doi: 10.1161/01.CIR.0000092890.29552.22. Epub 2003 Sep 29. Circulation. 2003. PMID: 14517168
-
Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?Circulation. 2004 Oct 12;110(15):2175-9. doi: 10.1161/01.CIR.0000144303.24894.1C. Epub 2004 Oct 4. Circulation. 2004. PMID: 15466649
Cited by
-
Matrix Signaling Subsequent to a Myocardial Infarction: A Proteomic Profile of Tissue Factor Microparticles.JACC Basic Transl Sci. 2017 Oct 30;2(5):529-542. doi: 10.1016/j.jacbts.2017.04.004. eCollection 2017 Oct. JACC Basic Transl Sci. 2017. PMID: 30062169 Free PMC article.
-
Potential Markers in Cardiac Hypertrophy?EJIFCC. 2012 Jul 18;23(2):41-6. eCollection 2012 Jul. EJIFCC. 2012. PMID: 27683411 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical